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Abstract
Bacterial pneumonia is a common public health problem associated
with significant mortality, morbidity, and cost. Neutrophils are
usually the earliest leukocytes to respond to bacteria in the lungs.
Neutrophils rapidly sequester in the pulmonary microvasculature
and migrate into the lung parenchyma and alveolar spaces, where
they perform numerous effector functions for host defense. Previous
studies showed that migrated neutrophils produce IFN-g early
during pneumonia induced by Streptococcus pneumoniae and that
early production of IFN-g regulates bacterial clearance. IFN-g
production by neutrophils requires Rac2, Hck/Lyn/Fgr Src family
tyrosine kinases, andNADPHoxidase.Our current studies examined
the mechanisms that regulate IFN-g production by lung neutrophils
during acute S. pneumoniae pneumonia in mice and its function.
We demonstrate that IFN-g production by neutrophils is a tightly
regulated process that does not require IL-12. The adaptor molecule
MyD88 is critical for IFN-g production by neutrophils. The guanine
nucleotide exchange factor CalDAG-GEFI modulates IFN-g
production. The CD11/CD18 complex, CD44, Toll-like receptors 2
and 4, TRIF, and Nrf2 are not required for IFN-g production by
neutrophils. The recently described neutrophil–dendritic cell hybrid
cell, identified by its expression of Ly6G and CD11c, is present at
low numbers in pneumonic lungs and is not a source of IFN-g.
IFN-g produced by neutrophils early during acute S. pneumoniae
pneumonia induces transcription of target genes in the lungs, which
are critical for host defense. These studies underline the complexity
of the neutrophil responses during pneumonia in the acute
inflammatory response and in subsequent resolution or initiation
of immune responses.
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Clinical Relevance
This research adds to our knowledge base of pneumonia
and how host defense occurs and to our understanding of
neutrophils and their function during inflammation. This
research affects clinical medicine by suggesting that targeting
neutrophil function, particularly the production of IFN-g, will
modulate host defense, resolution of inflammation, and the
initiation of the innate and specific immune processes.
Bacterial pneumonia is a common public
health problem with considerable morbidity
and mortality (1). It is one of the most
common precursors to the development of
acute lung injury and acute respiratory
distress syndrome. Neutrophils are usually
the earliest leukocyte to respond to bacteria
in the lungs. Neutrophils rapidly sequester
in the pulmonary microvasculature and
migrate into the lung parenchyma and
alveolar spaces where they perform
numerous effector functions.
Recent studies have shown that
neutrophils can no longer be considered
simply carriers of the machinery to produce
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superoxide and other reactive oxygen
species (ROS) and proteases but rather that
they are very capable of transcribing and
translating proteins in a regulated manner
(2). The mediators that they produce
depend on the inflammatory stimulus and
the lung environment. For example, our
recent studies have shown that migrated
neutrophils produce IFN-g during
pneumonia induced by Streptococcus
pneumoniae and Staphylococcus aureus, but
not in pneumonias caused by Escherichia
coli or Pseudomonas aeruginosa, when
assessed by flow cytometry, mass
spectroscopy, or ELISA (3). At this time
early in the evolution of pneumonias,
98% of the IFN-g–expressing cells are
neutrophils (3). This IFN-g is important
in host defense because at 24 hours after
intratracheal instillation of S. pneumoniae
bacterial clearance was impaired in mice
deficient in IFN-g (3). Our studies showed
that one mechanism through which IFN-g
regulates bacterial clearance is by regulating
the production of neutrophil extracellular
traps (3).
Very little is understood about the
pathways through which IFN-g is induced
in neutrophils. The cytokine IL-12 is
produced by dendritic cells, neutrophils,
and monocytes/macrophages and induces
inflammatory processes, including IFN-g
production by lymphocytes and natural
killer (NK) cells (4). Several studies have
shown that IL-12 can also induce IFN-g
















































































Figure 1. Lung neutrophils produce IFN-g during Streptococcus pneumoniae (SP) pneumonia. (A) Dot plots show Ly6G and IFN-g expression of lung
cells from wild-type (WT) mice given PBS or SP. Cells were gated to exclude debris and doublets. Neutrophils were identified by high expression of
Ly6G. (B) Representative histogram shows IFN-g expression of neutrophils from the lungs of WT mice given PBS or SP. The percentage of high IFN-g
expressors was determined by setting the threshold of staining above that seen with the isotype-matched antibody control, effectively excluding cells
with dim or moderate staining. The percentage of cells expressing moderate or high IFN-g was determined by creating gates based on scatter and
staining characteristics and setting the staining threshold with the negative staining controls at <2%. (C) The total number of neutrophils in the left
lung and the percentage of IFN-g1 neutrophils in the lung in WT mice at 24 hours after intratracheal instillation of PBS or SP. Data are expressed as mean 6
SEM (n = 4). High expression: the percentage of neutrophils with high expression, as calculated using analysis 1, as described in MATERIALS AND METHODS.
High 1 moderate: the percentage of neutrophils that expressed either moderate or high levels of IFN-g, as calculated using analysis 2. *P , 0.05
compared with PBS instillation.
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cells (5–7). A critical mediator of
IL-12 signaling is signal transducer and
activator of transcription (STAT) 4, which
is phosphorylated upon IL-12 binding to its
receptor (8, 9). Phosphorylated STAT4 then
translocates to the nucleus and binds to
target genes to regulate their transcription.
Our initial studies tested the hypothesis
that IL-12 is required for IFN-g production
by neutrophils through a STAT4-dependent
pathway. Because the studies presented in this
manuscript show no role for IL-12 in IFN-g
production by neutrophils, other hypotheses
were pursued.
Our previous studies provided clues
about important pathways for neutrophil
production of IFN-g. Three nonreceptor
Src family kinases expressed on neutrophils
(Hck, Fgr, and Lyn), the small GTPase
Rac2, and the gp91phox (Nox2) component
of the phagocyte NADPH oxidase
are required for IFN-g production by
neutrophils during S. pneumoniae
pneumonia (3). A signaling pathway in
which the Src family kinases activate Rac2
and leads to assembly and activation of the
NADPH oxidase has been described (10).
The NADPH oxidase complex catalyzes
the production of superoxide from oxygen,
which leads to a cascade of ROS and
potentially to oxidative stress (11). This
stress activates the transcription factor
Nrf2, which switches on cytoprotective
pathways by regulating transcription of
antioxidant and detoxifying genes (12, 13).
Recent reports have also demonstrated
a requirement for Nrf2 in regulating the
innate immune response during infection
or injury (14–20). Whether the observed
role of NADPH oxidase in IFN-g
production is due to Nrf2 target genes
regulating IFN-g is an important question
we address. Furthermore, three members of
the Src family kinases (Fgr, Hck, and Lyn),
Rac2, and NADPH oxidase are downstream
of signaling induced by the CD11/CD18
leukocyte adhesion complex (10, 21–24).
The glycoprotein CD44, a major receptor for
hyaluronan and other extracellular matrix
components, is also important for activating
b2 integrins (25). The studies described
herein also seek to determine whether
CD11/CD18 and CD44 are required for the
production of IFN-g by neutrophils.
Toll-like receptors (TLRs) initiate
signaling cascades and induce production of
mediators in response to pathogens. Of
particular interest for this study are TLR2,
which recognizes whole S. pneumoniae and
peptidoglycan from the cell wall of gram-
positive organisms (26, 27), and TLR4,
which is best known for recognizing LPS
but also capable of recognizing other
ligands, including the pneumococcal pore-
forming toxin pneumolysin (28). TLR2 also
appears to contribute to the host response
to purified pneumolysin in vivo (29). The
initial signaling immediately downstream
of TLRs is mediated by the TIR-
domain–containing adaptors MyD88 and
TRIF (30). MyD88 mediates signaling
downstream of all TLRs except TLR3 and
in some cases TLR4, whereas TRIF
mediates MyD88-independent signaling
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Figure 2. IL-12 is not required for IFN-g production by neutrophils. (A) The total number of
neutrophils in the left lung and the percentage of IFN-g1 neutrophils in the lung were similar in WT
and IL-12a–deficient (Il12a2/2) mice at 24 hours after intratracheal instillation of SP. Data are expressed
as mean 6 SEM; n = 7 (WT) and n = 8 (Il12a2/2). *P , 0.05 compared with WT mice. (B) STAT4
is expressed by neutrophils but is not phosphorylated in neutrophils during SP pneumonia. The
phosphorylated form of STAT4 (pSTAT4) was not detected in neutrophils isolated from lungs of two WT
mice 6 hours after intratracheal instillation of PBS or SP. PBS- and SP-treated neutrophils expressed
total STAT4. pSTAT4 was detected in isolated WT splenocytes incubated in the presence of media
(Med), SP, or phorbol ester (PMA). (C) STAT4 in lung neutrophils is not immunoprecipitated by an
antibody that recognizes phosphorylated tyrosine residues (PY20). Neutrophils were isolated from the
lungs of WT mice 6 hours after intratracheal administration of PBS or SP. The neutrophils were lysed,
and immunoprecipitation with the antiphosphotyrosine antibody was performed using standard
procedures. IP, immunoprecipitated fraction; S, supernatant (nonimmunoprecipitated fraction). The
positive control was obtained from splenocytes treated with PMA for 4 hours.
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MyD88 regulates neutrophil recruitment to
the lung during bacterial pneumonia (34,
35). TRIF is critical for host responses in
pneumonias caused by the gram-negative
organisms E. coli (36), Klebsiella
pneumoniae (37), and P. aeruginosa (38).
Our studies thus pursued questions
about the mechanisms through which IFN-
g expression in neutrophils is regulated
during S. pneumoniae pneumonia. Because
these studies show that IL-12 is not
a regulator of IFN-g expression, whereas
nonreceptor Src tyrosine kinases, Rac2, and
NADPH oxidase are required for IFN-g
production (3), subsequent studies tested
hypotheses about what is downstream and
upstream of these signaling molecules.
These hypotheses tested the role of the
oxidant stress–activated transcription factor
Nrf2 in regulating IFN-g production and of
NADPH oxidase–generated ROS in
regulating mitogen-activated protein kinase
(MAPK). A role for the CD11/CD18
adhesion complex (b2 leukocyte integrins)
was postulated because the complex is
upstream of these signaling molecules and
because CD11b/CD18 is also a complement
receptor (CR3); a role for CD44 was also
postulated. These studies also tested the
hypothesis that TLR2 and TLR4 and the
TLR downstream adaptor molecules
MyD88 and TRIF are important regulatory
molecules in IFN-g production by
neutrophils.
Materials and Methods
Further details are provided in the online
supplement.
Mice
Adult C57BL/6 wild-type (WT) and mutant
mice backcrossed for >10 generations were
purchased or obtained from collaborators.
Age- and gender-matched mice were studied
at 6 to 8 weeks of age. All animal studies
were performed in compliance with the
United States Department of Health and
Human Services Guide for the Care and Use
of Laboratory Animals. Animal studies were
reviewed and approved by our Institutional
Animal Care and Use Committee.
Bacterial Pneumonia
Pneumonia was induced by intratracheal
instillation of S. pneumoniae (serotype 19,
ATCC 49619) suspended in PBS into the left
lung at a dose of 2.3 ml/g mouse body weight
(details are provided in the online supplement).
Bone marrow (BM) chimeric mice were
generated as described in the online supplement.
Isolation of single lung cells,
immunostaining to identify neutrophils and
intracellular IFN-g, and flow cytometry data
analysis were performed as previously
described (3) and are detailed in the online
supplement. Isolation of neutrophils from
single cell suspensions of mouse lungs was
performed using biotin–anti-Ly6G and
magnetic beads coated with antibiotin (MACS
beads; Miltenyi Biotec, San Diego, CA).
Gene expressionprofiling usingAffymetrix




Hybrids, Produce IFN-g during
S. pneumoniae Pneumonia
S. pneumoniae caused a large increase in
the number of neutrophils in the lung
Table 1. The Level of IFN-g Expression by Neutrophils From Mice with Targeted
Mutations in the Indicated Molecules Compared with Wild-Type Mice*
Molecule Deficient in
Deficient Mice
MFI of All Neutrophils MFI of IFN-g1 Neutrophils
Deficient WT Deficient WT
IL-12a 15 6 1.5 16 6 1.4 32 6 1.3 33 6 2.1
Nrf2 19 6 1.8 19 6 1.7 30 6 2.5 29 6 2.2
gp91phox 2.3 6 0.7* 19 6 1.7 13 6 1.2† 29 6 2.2
CD11a 14 6 2.0 20 6 1.3 43 6 2.0 43 6 0.7
CD11b 24 6 4.1 20 6 1.3 44 6 4.6 43 6 0.7
CD18 (Chimeric mice) 15 6 2.0 16 6 2.4 27 6 1.0 29 6 1.6
CalDAG GEFI 16 6 2.3 (P = 0.05) 9.9 6 0.6 31 6 2.2 25 6 1.0
CD44 8.9 6 1.2 8.0 6 1.0 31 6 1.0 33 6 1.6
TLR2/4 11 6 1.9 13 6 1.8 31 6 1.5 32 6 2.1
TLR2 11 6 2.9 13 6 1.8 32 6 0.2 32 6 2.1
TLR4 14 6 1.6 13 6 1.8 34 6 1.7 32 6 2.1
Definition of abbreviations: MFI, median fluorescence intensity; TLR, Toll-like receptor; WT, wild type.
*The data show the MFI of lung neutrophils and of IFN-g–expressing lung neutrophils in age- and
gender-matched mutant and WT mice during 24-h Streptococcus pneumoniae pneumonia. MFI was
estimated as the median channel value for all events that meet the gating criteria after subtracting the
signal of the respective isotype control. Values are mean 6 SEM.
†P < 0.05 compared with WT (t test or ANOVA with Scheffe post hoc test as appropriate).








or High Levels of IFN-g (%)
Deficient WT Deficient WT Deficient WT
CD11a 64 6 5.9 48 6 4.3 16 6 1.3 18 6 0.9 36 6 2.2 45 6 3.0
CD11b 44 6 6.5 48 6 4.3 19 6 4.3 18 6 0.9 44 6 2.7 45 6 3.0
CD18 (Chimeric mice) 49 6 6.1† 0.38 6 0.10 21 6 1.8 23 6 1.8 56 6 4.5 58 6 5.1
CD44 21 6 5.1 17 6 5.1 25 6 1.5 25 6 2.9 42 6 3.2 41 6 3.8
Definition of abbreviation: WT, wild type.
*The number of lung neutrophils in the pneumonic lung and the percentage that express IFN-g in mutant and age- and sex-matched WT mice during 24-h
Streptococcus pneumoniae pneumonia are shown. Values are mean 6 SE.
†P < 0.05 compared with WT (t test or ANOVA with Scheffe post hoc test as appropriate). Data are from at least two experiments.
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(Figure 1). Consistent with our previously
published work (3), neutrophils in the
pneumonic lung produced IFN-g during
pneumonia induced by S. pneumoniae
(Figure 1). The median fluorescence
intensity (MFI) of IFN-g staining was
significantly higher in neutrophils
from mice given S. pneumoniae
compared with that of neutrophils from
mice given PBS, whether comparing all
neutrophils (20 6 2.3 versus 2.1 6 0.3,
respectively) or neutrophils expressing
IFN-g (31 6 1.1 versus 16 6 0.5,
respectively).
Our published data show that T cells,
NK cells, and macrophages are not
producing IFN-g at 24 hours (3). In fact, .
98% of the IFN-g–expressing cells in lung
digests are neutrophils, as marked by high
expression levels of Ly6G. Recent reports
have indicated that CD11c-expressing
neutrophils arise during inflammation and
may be important in bacterial clearance and
antigen presentation by functioning as
neutrophil–dendritic cell hybrids (39, 40).
The number of lung cells coexpressing
CD11c and Ly6G was greater in WT mice
with S. pneumoniae pneumonia compared
with those given PBS (4.0 6 0.73 3 104
versus 0.13 6 0.04 3 104 [n = 4]; P , 0.05
using t test). However, CD11c1 Ly6G1
cells constituted a minuscule proportion of
cells in the lungs of S. pneumoniae and PBS-
treated mice (0.08 6 0.02% versus 0.01 6
0.0%, respectively) and a very low proportion
of the IFN-g1 cells expressed CD11c in
mice with S. pneumoniae pneumonia (0.4 6
0.3%). These data indicate that CD11c1
neutrophils are not contributing to IFN-g
production during pneumonia.
IL-12 Is Not Required for IFN-g
Production by Lung Neutrophils
IL-12a–deficient mice lack the unique p35
subunit of IL-12 and express decreased





































Figure 3. Deficiency of CalDAG-GEFI augments IFN-g production by neutrophils. The percentage of
lung neutrophils expressing IFN-g is significantly higher in CalDAG-GEFI–deficient (Rasgrp22/2) mice
compared with WT mice. Data are mean6 SEM from four separate experiments; n = 10 (WT) or n = 8
(Rasgrp22/2). *P , 0.05 compared with WT mice (t test).
Table 3. MyD88 but Not TRIF Modulates Expression of IFN-g in Lung Neutrophils, Particularly Those in the Bronchoalveolar Lavage
Fluid*
Lung Neutrophils
Study Comparing WT and
Myd882/2 Mice
Study Comparing WT and
Ticam12/2 Mice
Myd882/2 WT Ticam12/2 WT
Total neutrophils in BALF 3106 1.0 6 0.1† 3.2 6 0.4 5.4 6 0.3† 3.9 6 0.2
% IFN-g1 neutrophils in BALF
% high 13 6 1.6† 27 6 3.2 26 6 2.2 24 6 2.2
% high 1 moderate 28 6 3.4† 51 6 4.6 51 6 7.6 51 6 6.4
Total neutrophils in lung digest after BAL 3106 19 6 2.0 21 6 4.0 22 6 1.3 23 6 3.0
% IFN-g1 neutrophils in lung tissue after BALF
% high 16 6 2.6† 30 6 2.4 29 6 1.9 22 6 3.3
% high 1 moderate 22 6 4.1‡ 36 6 5.6 56 6 3.6 50 6 6.6
MFI of all neutrophils
BALF 5.9 6 0.9† 16 6 2.4 11 6 1.0 11 6 0.6
Lung digest 5.0 6 1.0† 14 6 1.2 11 6 1.0 9.0 6 1.1
MFI of IFN-g1 neutrophils
BALF 30 6 1.4 33 6 3.0 24 6 3.2 23 6 2.2
Lung digest 39 6 2.3 48 6 7.1 23 6 1.9 20 6 1.4
Definition of abbreviations: BAL, bronchoalveolar lavage; BALF, bronchoalveolar lavage fluid; MFI, median fluorescence intensity; WT, wild type.
*The role of MyD88 and TRIF was examined in neutrophils in BALF and lung tissue after lavage. Flow cytometry was performed to detect intracellular IFN-g
levels in neutrophils (Ly6G1) in the BALF and in the lung tissue after lavage of Streptococcus pneumoniae–infected mice. Isotype-matched control
antibody was used for assessing the level of background staining. The mutant genotypes were compared with gender- and age-matched WT mice. Data
are expressed as the mean 6 SEM (n = 5–7).
†P < 0.05 compared with WT using two-tailed t tests.
‡P = 0.07 compared with WT (t test).
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Listeria monocytogenes (41). The number
of neutrophils that migrated into the
lungs was similar in WT and IL-12–
deficient (Il12a2/2) mice during 24-hour
S. pneumoniae pneumonia. The percentage
of Ly6G-negative cells that expressed
IFN-g was similarly low in WT and IL-
12–deficient mice (1.4 6 0.3% versus 1.1 6
0.3%, respectively). In WT mice, over half
the lung neutrophils expressed IFN-g
(Figure 2). Most importantly, the
percentage of IFN-g1 neutrophils was
similar in WT and IL-12a–deficient mice
when gating was based on high expression
(analysis 1) or on moderate and high
expression (analysis 2) (Figure 2A). The
IFN-g MFI and the distribution of intensity
of IFN-g staining was also not different
between genotypes (Table 1). These data
indicate that IL-12 is not required for
IFN-g production by neutrophils.
IL-12 activates the transcription factor
STAT4, which plays a critical role in IFN-g
production by lymphocytes and NK cells
(8, 9). STAT4 is expressed in neutrophils
from the lungs of mice given PBS or
S. pneumoniae (Figure 2B). However, the
phosphorylated form of STAT4 was not
detected in these lung neutrophils using an
antibody specific for STAT4 phosphorylated
at tyrosine 693 or after immunoprecipitation
of tyrosine-phosphorylated proteins
with an antiphosphotyrosine antibody
(Figure 2C). Taken together, these studies
suggest that IL-12 and phosphorylation
of STAT4 are not required for IFN-g
expression by neutrophils during
S. pneumoniae pneumonia.
The Leukocyte Adhesion Complex
CD11/CD18 Does Not Contribute to
IFN-g Production
Our previous study demonstrated that
production of IFN-g by neutrophils during
S. pneumoniae pneumonia required Rac2,
the Src family kinases Hck/Fgr/Lyn, and the
gp91phox component of NADPH oxidase
(3). Studies in the literature have demonstrated
that these molecules are downstream of
leukocyte integrin engagement in outside-in
signaling pathways that modulate neutrophil
adhesion, motility, and activation (21, 22, 24,
42). To determine the role of adhesion
molecules in IFN-g production by
neutrophils, mice deficient in leukocyte
b2 integrins (the CD11/CD18 adhesion
complex) were studied.
The leukocyte integrin CD11/CD18
expressed on neutrophils mediates adhesion
of neutrophils to endothelial cells and to
bacteria. CD11a/CD18 (LFA-1) and CD11b/
CD18 (Mac1 or CR3) can bind ICAM-1
expressed on endothelial and other cells.
CD11b/CD18 can also bind to the
complement fragment iC3b-coating
bacteria, extracellular matrix components,
or other cells.
The role of the CD11a/CD18 and
CD11b/CD18 in initiating IFN-g expression
was studied using mice deficient in CD11a
or CD11b. The total number of lung
neutrophils in the pneumonic lung and
the percentage of lung neutrophils that
expressed both high and moderate levels
of intracellular IFN-g were not different
among CD11a-deficient (Itgal2/2), CD11b-
deficient (Itgam2/2), and WT mice
(Table 2). The intensity of IFN-g staining
tended to be less in neutrophils from
CD11a-deficient mice, but this trend was
not statistically significant (Table 1). These
data indicate that CD11a/CD18 and







Neutrophils Expressing Moderate or High
Levels of IFN-g (%)
Deficient WT Deficient WT Deficient WT
TLR2/4 23 6 1.1 29 6 3.2 20 6 3.7 24 6 3.0 38 6 7.3 44 6 4.5
TLR2 24 6 1.7 29 6 3.2 20 6 5.2 24 6 3.0 37 6 8.6 44 6 4.5
TLR4 31 6 5.0 29 6 3.2 26 6 3.7 24 6 3.0 46 6 6.0 44 6 4.5
Definition of abbreviations: TLR, Toll-like receptor; WT, wild type.
*TLR2 and TLR4 are not required for IFN-g production by neutrophils. No significant difference in the total number of neutrophils and the percentage of
IFN-g1 neutrophils in the pneumonic lung in coincidently studied WT and mice lacking TLR2 (Tlr22/2), TLR4 (Tlr42/2), or both TLR2 and TLR4 (Tlr2/42/2).
Data are mean 6 SEM (n = 4–5 per genotype).
Table 5. Toll-Like Receptors 2 and 4 Are Not Required for IFN-g Expression by
Neutrophils in the Airspace and Lung Tissue*
Lung Neutrophils Tlr2/42/2 WT
Total neutrophils in BALF 3106 3.5 6 0.4 3.0 6 0.7
% IFN-g1 neutrophils in BALF
% high 35 6 10 37 6 9.2
% high 1 moderate 50 6 5.4 54 6 2.7
Total neutrophils in lung digest after BAL 3106 38 6 7.4 26 6 5.2
% IFN-g1 neutrophils in lung tissue after BALF
% high 35 6 3.8 44 6 7.6
% high 1 moderate 51 6 7.9 56 6 10.4
MFI of all neutrophils
BALF 8.7 6 2.1 9.6 6 1.5
Lung digest 8.8 6 2.3 11 6 3.2
MFI of IFN-g1 neutrophils
BALF 17 6 1.9 17 6 1.9
Lung digest 18 6 3.2 17 6 2.9
Definition of abbreviations: BAL, bronchoalveolar lavage; BALF, bronchoalveolar lavage fluid; MFI,
median fluorescence intensity; TLR, Toll-like receptor; WT, wild type.
*IFN-g expression was determined in neutrophils (Ly6G1) in the BALF and in the lung tissue after
lavage of Streptococcus pneumoniae–infected WT mice and mice lacking both TLR2 and TLR4
(Tlr2/42/2). No significant differences were found using t test to compare genotypes (n = 4 from
two separate experiments).
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CD11b/CD18 are not required for IFN-g
production by neutrophils.
A direct comparison of WT and CD18-
deficient neutrophils was made by
reconstituting lethally irradiated WT mice
with a mixture of WT and CD18-deficient
BM cells. The total number of lung
neutrophils in chimeric mice was similar
to the number of lung neutrophils in WT
mice in the study addressing the roles of
CD11a and CD11b (Table 2). The
proportion of neutrophils that are CD18
deficient is much higher in the lung than in
the blood (99.5 6 0.2% versus 42 6 4.8%,
respectively), suggesting that CD18-
deficient neutrophils are retained and may
preferentially migrate in the lungs. The
proportion of WT and CD18-deficient lung
neutrophils that made IFN-g was similar
(Table 2), as was the level of IFN-g
expression. Taken together, these data
indicate that CD11/CD18 adhesion
complex is not required for IFN-g
production by neutrophils. Thus, Rac2, the
Src kinases Hck/Fgr/Lyn, and NADPH
oxidase mediate IFN-g production through
pathways that do not require ligation of b2
integrins on the neutrophil surface.
Signaling through CalDAG-GEFI
Suppresses IFN-g Production
CalDAG-GEFI is a guanine nucleotide
exchange factor regulated by calcium. It
acts as an activator of b2 integrins in
neutrophils and other integrins in platelets
by activating Rap1. The proportion
of neutrophils expressing IFN-g was
significantly greater in CalDAG-
GEFI–deficient (Rasgrp22/2) mice
compared with WT mice (Figure 3), and
the intensity of IFN-g staining tended to
be greater (Table 1). Thus, signaling by
CalDAG-GEFI appears to inhibit rather
than induce IFN-g expression by
neutrophils.
CD44 Does Not Contribute to
IFN-g Production
CD44 is a major receptor for hyaluronan
and binds collagen and E-selectin. Several
reports have indicated that CD44 ligation
can up-regulate the expression of ICAM-1
and modulate integrin-dependent adhesion
(43–45) as well as activate b2 integrins
on macrophages (25). However, the
proportion of IFN-g–producing neutrophils
in CD44-deficient mice and the intensity
of IFN-g expression were not different
compared with those in WT mice, indicating
that CD44 is not required for IFN-g
production by neutrophils (Tables 1 and 2).
MyD88 but Not TRIF Regulate
IFN-g Production
Neutrophil numbers in the bronchoalveolar
lavage fluid (BALF) were significantly less
in MyD88-deficient (Myd882/2) mice
compared with WT mice (Table 3), consistent
with the previously described role of MyD88
in regulating neutrophil recruitment during
pulmonary inflammation (34, 35). The
percentage of IFN-g1 neutrophils and the
intensity of IFN-g staining in neutrophils
in the BALF and lung tissue after lavage
were significantly less in Myd882/2 mice,
indicating a role for MyD88 in mediating
IFN-g production by neutrophils (Table 3).
The percentages of IFN-g1 neutrophils and
the intensity of IFN-g staining of neutrophils in
the BALF and lung tissue after lavage were
similar in WT and TRIF-deficient (Ticam12/2)
mice (Table 3), indicating that TRIF is not
required for IFN-g production by neutrophils
during S. pneumoniae pneumonia. The total
number of neutrophils in the BALF was
significantly higher in the Ticam12/2 mice;
consequently, the number of IFN-g1 cells in
the BALF was significantly higher in Ticam12/2
compared with WT mice.
TLR2 and TLR4 Do Not Contribute to
IFN-g Production
The role of TLR2 and TLR4 in IFN-g
production by neutrophils in
S. pneumoniae pneumonia was examined
using mice singly deficient in TLR2 (Tlr22/2)
or TLR4 (Tlr42/2) or mice lacking both
TLR2 and TLR4 (Tlr2/42/2). Mice singly
deficient in TLR2 or TLR4 were examined
coincidently with WT and Tlr2/42/2 mice.
There was no significant difference in the
proportion of IFN-g1 neutrophils or in the
total number of neutrophils in the lung
when comparing all four genotypes
(Table 4).
To examine the role of TLR2 and TLR4
in neutrophil recruitment to the lungs and
IFN-g production, neutrophils in the
BALF and neutrophils remaining in the
lung tissue after lavage were assessed. No
significant differences were observed
between WT and Tlr2/42/2 mice in the
number of neutrophils, in the proportion
that expressed IFN-g, or in the intensity
of IFN-g staining in the BALF and lung
tissue after lavage (Table 5). These studies
suggest that TLR2 and TLR4 are not
required for neutrophil recruitment to the
lungs or IFN-g production by neutrophils
at 24 hours during S. pneumoniae
pneumonia.
NADPH Oxidase–Generated Oxidants
Are Required for IFN-g Production,
but Nrf2 and Its Gene Products
Are Not
Our previous work showed that the gp91phox
(Nox2, gene name Cybb) component of the
phagocyte NADPH oxidase is required for





































Figure 4. NADPH oxidase is required for IFN-g production, but the redox-sensitive transcription
factor Nrf2 is not. The total number of neutrophils and the percentage of IFN-g1 neutrophils in the
pneumonic lung in WT, Nrf2-deficient (Nfe2l22/2), and Nox2 (gp91phox)-deficient (Cybb2/2) mice.
Data are mean6 SEM (n = 3–5). *P< 0.05 compared with the other groups (ANOVA with Tukey HSD
post hoc test). Similar results were obtained in a separate study.
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IFN-g production by neutrophils (3). In
neutrophils, NADPH oxidase is the main
source of superoxide. Free radicals such
as superoxide can cause oxidative stress,
which in turn activates the cytoprotective
transcription factor Nrf2. To determine
whether Nrf2 is required for the production
of IFN-g by neutrophils, Nrf2-deficient
(Nfe2l22/2) mice were studied concurrently
with WT and Nox2-deficient (Cybb2/2)
mice. The percentage of lung neutrophils
that expressed intracellular IFN-g was
similar in WT mice and Nrf2-deficient
mice (Figure 4) whether high expressors or
high 1 moderate expressors are compared.
The level of expression was also not
different in these two genotypes when
compared using the MFI or the distribution
of IFN-g staining (Table 1). In contrast,
neutrophils from Nox2-deficient mice
expressed almost no IFN-g (Figure 4), and
the MFI was similarly low and not different
from isotype controls (Table 1). The
number of neutrophils in the lungs was not
significantly different among WT, Nrf2-
deficient, and Nox2-deficient mice
(Figure 4). These data indicate that Nrf2
and Nrf2-dependent target genes are
not required for IFN-g production by
neutrophils. NADPH oxidase may regulate
IFN-g production by modulating other
oxidant-sensitive transcription factors and
pathways.
To rule out the possibility that the
defect in IFN-g production observed in
Nox2-deficient mice is due to differences
in cell death, membrane integrity and
apoptosis were assessed in lung neutrophils
from WT and Nox2-deficient mice.
Membrane integrity of lung neutrophils
was similarly high in WT and Nox2-
deficient mice, as assessed with a fixable
viability dye (94 6 1% versus 95 6 0.2%,
respectively [n = 4]). The percentage of
viable neutrophils was similar between
IFN-g expressors and nonexpressors in
both genotypes. Cell viability as determined
by 7-AAD exclusion was slightly less in WT
compared with Nox2-deficient mice (90 6
0.4% versus 92 6 0.6%, respectively; P ,
0.05, t test). The proportion of neutrophils
that bound Annexin V on their surface
but excluded 7-AAD (consistent with
membrane changes that occur early during
apoptosis) was not significantly different
between WT and Nox2-deficient
mice (26 6 3.8% versus 34 6 2.7%,
respectively). Thus, differences in
neutrophil viability are unlikely to be the
reason for the lack of IFN-g production in
the absence of Nox2.
MAPK activity depends on
phosphorylation of a few critical residues,
which is regulated by kinases and
phosphatases. ROS modulate the activity
of MAPKs by inhibiting phosphatases,
resulting in sustained MAPK activation (46,
47). The levels of phosphorylated and total
MAPKs were determined in neutrophils
isolated from the lungs of WT and Nox2-
deficient mice given S. pneumoniae. There
was no significant difference between WT
and Nox2-deficient neutrophils in the
levels of phosphorylated or total p38 and
extracellular signal-regulated kinases (ERK)
MAPK or in the level of total c-Jun N-
terminal kinase (JNK) (Figure 5). However,
phosphorylated JNK was significantly
greater in Nox2-deficient neutrophils
compared with WT neutrophils by
approximately 30% (Figure 5). Thus, ROS
appear to be regulating JNK activity during
S. pneumoniae pneumonia by limiting the
amount of JNK in its phosphorylated
active state.
IFN-g Produced Early during Acute
S. pneumoniae Pneumonia Regulates
Gene Transcription in the Lungs
To determine the effect of neutrophil IFN-g


















































Figure 5. Deficiency of Nox2 results in augmented phosphorylation of c-Jun N-terminal kinase (JNK)
and no change in phosphorylation of extracellular signal-regulated kinases (ERKs) or p38 mitogen-
activated protein kinases (MAPKs) in neutrophils. The total amount of each MAPK was similar in the
two genotypes. Representative immunoblots showing protein levels of phosphorylated and total
MAPKs in lung neutrophils from WT and Nox2-deficient (Cybb2/2) mice during S. pneumoniae
pneumonia. Graphs show densitometric measurements in arbitrary units (AU) (mean 6 SEM; n = 4–5
mice per genotype repeated in two or three separate experiments). *P < 0.05 compared with WT
(t test).
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irradiated and reconstituted with either WT
or Ifng2/2 BM. They were studied after 3 to
4 weeks, when virtually all neutrophils are
donor derived. Gene expression in lungs
from these mice was profiled at 24 hours
after intratracheal administration of PBS
(control) or after a low or high dose of
S. pneumoniae. In Ifng2/2 mice given PBS,
no genes were differentially expressed in
mice reconstituted with WT compared with
Ifng2/2 BM, using standard filtering criteria
(FDR-adjusted P < 0.05; fold change > 2).
Administration of a high dose of
S. pneumoniae resulted in differential
expression of 3,013 and 2,667 transcripts in
mice reconstituted with WT or Ifng2/2
cells, respectively, and administration of
a low dose of S. pneumoniae induced 2,577
and 2,436 transcripts in mice reconstituted
with WT or Ifng2/2 BM cells, respectively
(Table 6). Transcripts that were uniquely
changed by S. pneumoniae in Ifng2/2 mice
reconstituted with WT BM compared with
Ifng2/2 mice reconstituted with Ifng2/2
BM were identified (Table 6). However,
a number of these unique transcripts were
close to the statistical cutoff of 2.0-fold
change, so that the ratio of the fold change
in WT BM compared with the fold change
in Ifng2/2 BM was often close to 1. When
this ratio was calculated for all genes
counted in Table 6, far fewer had a ratio
greater than 1.5 (Table 7). There were
22 genes in both low- and high-dose
pneumonias that showed a ratio of over
1.5 (i.e., were 50% greater in WT BM
compared with Ifng2/2 BM), and these
transcripts are listed in Table E1 in the
online supplement. Eight of these genes are
known to be IFN-g regulated (bold font).
IFN-g mRNA was barely detectable
in all mice given PBS. In the mice
reconstituted with WT BM, IFN-g
expression was up-regulated 10-fold and
9.6-fold during high- and low-dose
pneumonia, respectively. The Ifng2/2 mice
have a stop codon in exon 2 of the Ifng
gene. However, variable-length mRNA is
produced that is recognized by the probes
that target the Ifng gene. Expression of the
mutant Ifng mRNA in mice reconstituted
with Ifng2/2 BM was up-regulated 1.8-fold
and 2.1-fold at high- and low-dose
pneumonia, respectively, and these changes
were significantly less compared with those
observed in mice with WT BM (adjusted
P , 0.001, ANOVA). This mRNA appears
unstable because less was produced, but
a stop codon in exon 2 would not be
expected to affect the promoter region’s
function.
There were 22 transcripts whose
expression was at least 2-fold greater in WT
BM-reconstituted mice compared with
Ifng2/2 BM-reconstituted mice during low-
and high-dose pneumonia (Table 8).
Except for Ciita, Pydc3, and GM22079, the
expression of the remaining 19 transcripts
was increased during high-dose S.
pneumoniae pneumonia compared with
PBS in mice reconstituted with Ifng2/2 BM,
indicating that the effect of IFN-g is partial.
Ciita expression was down-regulated
during pneumonia in mice reconstituted
with Ifng2/2 BM cells, and Pydc3 and
GM22079 were unchanged, suggesting that
IFN-g is required for their up-regulation.
Of the 22 differentially expressed
transcripts, 18 have been previously
identified in the literature as IFN-g
inducible genes, as curated in NCBI Gene
and the Interferome database (48) (Table 8,
bold font). The expression of an additional
16 genes increased 1.5- to 2.0-fold in WT
BM-reconstituted mice compared with
Ifng2/2 BM-reconstituted mice during low-
and high-dose S. pneumoniae pneumonia,
and 10 of these are known to be regulated
by IFN-g (Table E2).
Gene Set Enrichment Analysis using
gene ontology (GO) sets showed that genes
involved in IFN-g signaling and other
immune response pathways were highly
statistically enriched in the lungs of mice
reconstituted with WT cells compared with
those reconstituted with Ifng2/2 cells
(Table 9). The IFN-g–inducible genes that
accounted for the enrichment score in
two GO sets focused on IFN-g–induced
responses (GO:0034341 and GO:0071346)
(Table 9) are shown in Table E3. Nine of
the genes in Table E2 were also identified in
Table 8 or Table E1 (Ciita, Gbp10, Gbp4,
Table 6. The Number of Up- or Down-Regulated Transcripts That Were Differentially
Expressed During High- or Low-Dose Streptococcus pneumoniae Pneumonia
Compared with PBS Controls in Ifng2/2 Mice That Were Reconstituted with Wild-Type
Bone Marrow or IFN-g–Deficient Bone Marrow or Were Expressed in Both (Common)*
Transcripts Up-Regulated > 2-Fold Down-Regulated > 2-Fold Total
High SP versus PBS
Common 1,101 1,214 2,315
Unique to WT BM 334 364 698
Unique to Ifng2/2 BM 141 211 352
Low SP versus PBS
Common 1,041 1,060 2,101
Unique to WT BM 188 288 476
Unique to Ifng2/2 BM 175 160 335
Definition of abbreviations: BM, bone marrow; SP, Streptococcus pneumoniae; WT, wild type.
*The hematopoietic system of Ifng2/2 mice was reconstituted with WT or Ifng2/2 BM cells.
Transcripts were considered to be differentially expressed after passing filtering criteria (FDR-adjusted
P < 0.05; fold change > 2 compared with PBS). n = 4 mice in each group.
Table 7. The Number of Genes in Table 6 That Also Met the Additional Criterion of the






High SP versus PBS
Common 131 39 170
Unique to WT BM 103 57 160
Unique to Ifng2/2 BM 22 22 44
Low SP versus PBS
Common 75 34 109
Unique to WT BM 50 30 80
Unique to Ifng2/2 BM 20 6 26
Definition of abbreviations: BM, bone marrow; SP, S. pneumoniae; WT, wild type.
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Table 8. Transcripts That Are Significantly Differentially Expressed 2-Fold or Greater in Ifng2/2 Mice Reconstituted with Wild-Type
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Gbp5, Irf1, Irgm2, Nlrc5, Socs1, and
Tgtp1).
STAT1 is downstream of the IFN-g
receptor and mediates most effects of IFN-g.
STAT1 is activated during S. pneumoniae
pneumonia, as demonstrated by GSEA
showing statistically significant enrichment
of genes involved in tyrosine phosphorylation
of STAT1 protein (GO:0042508 and
GO:0042510). Furthermore, STAT1 binding
sites are present upstream to the transcription
start site of all genes identified in Tables 8,
E2, and E3, many of which have been
experimentally confirmed (49, 50).
Taken together, these data indicate
that neutrophil-derived IFN-g regulates
gene expression in the lung during
S. pneumoniae pneumonia and thus shapes
the host response to bacteria in the lungs,
the resolution of inflammation, and the
initiation of the immune response.
Discussion
Our previous studies demonstrated that
neutrophils recruited to the lungs in
response to S. pneumoniae produce IFN-g
and that this IFN-g appears to contribute to
host defense (3). The studies presented here
sought to determine the signaling pathways
through which this IFN-g is produced by
neutrophils and the mechanisms through
which this IFN-g affects host defense and
innate immunity.
A growing body of work has shown
that neutrophils are capable of producing
cytokines and other mediators during
inflammation (2). IFN-g production
by neutrophils in the lung has been
documented in response to Nocardia
asteroides (51) or Saccharopolyspora
rectivirgula (52). Neutrophils also make
IFN-g during inflammation in other
tissues, including in the spleen during
infection with Salmonella (53) or L.
monocytogenes (54), during early graft loss
of pancreatic islet transplants (55), in
Table 8. (Continued )
Gene
Symbol* Description
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Definition of abbreviations: BM, bone marrow; SP, S. pneumonia; WT, wild type.
*Genes that have been previously described in the literature as IFN-g regulated are shown in bold.
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response to Francisella tularensis live
vaccine strain (56), and in the kidney
early in renal ischemia–reperfusion injury
(57). These reports suggest that IFN-g
production by neutrophils early during
infection or injury may be more widespread
than generally appreciated.
This rapidly produced IFN-g appears
to be almost entirely from neutrophils. At
24 hours, neutrophils account for .98%
of the IFN-g production, and none is
produced by T cells, NK cells, macrophages,
or neutrophil–dendritic cell hybrids. IL-12
is not required for IFN-g production by
neutrophils. IL-12–independent IFN-g
production has been suggested to occur
even in lymphocytes. For example,
lymphocytes from IL-12a-deficient mice are
still able to produce low levels of IFN-g (41,
58). IL-12–independent IFN-g production
could occur through IL-15 and/or IL-18.
IL-18 is produced by macrophages and
dendritic and other cells, and it can induce
IFN-g production by T lymphocytes and
NK cells in combination with IL-12 or
other factors in the absence of IL-12
(59–61). Neutrophils from the lungs of
mice exposed to S. rectivirgula produced
IFN-g when cultured in vitro with IL-12
and IL-18 or with IL-18 and IL-15 but not
when cultured with any cytokine alone
(62). Purified human peripheral blood
neutrophils cultured with IL-12 produced
a small amount of IFN-g, and IFN-g levels
were augmented by the addition of TNF
(63). Whether IL-18, IL-15, TNF, or other
cytokines induce IL-12–independent IFN-g
production by neutrophils in response to
S. pneumoniae in vivo has not been
determined. However, S. pneumoniae does
induce a small but significant increase in IL-15
and IL-18 mRNAs in the pneumonic lung.
Consistent with the finding that IL-12
is not required for IFN-g production by
neutrophils, STAT4 phosphorylation was
not detected in lung neutrophils. In T
lymphocytes and NK cells, the T-box
transcription factors T-bet and Eomes
regulate IFN-g production (64, 65). T-bet
has been implicated in IFN-g production
by T helper cells independent of IL-12 (66).
However, T-bet is expressed at almost
undetectable levels, and Eomes is not
significantly expressed in lung neutrophils
from mice given PBS or S. pneumoniae
(unpublished data). These findings
suggest that IFN-g gene transcription in
neutrophils may be regulated through
pathways distinct from those in other
cell types.
Our data indicate that CalDAG-GEFI
inhibits IFN-g expression. In neutrophils,
CalDAG-GEFI is critical for integrin
activation by activating the small GTPase
Rap1 downstream of G protein–coupled
receptor signaling (67) or rolling on E-
selectin (68). CalDAG-GEFI can mediate
neutrophil chemotaxis independent
of integrins by regulating the actin
cytoskeleton (69). The role of Rap1 in
inducing IFN-g is likely to be complex
due to its many functions in neutrophils,
endothelial cells, and other cells (70).
Whether CalDAG-GEFI regulates NADPH
oxidase or any of the other signaling
molecules required for IFN-g production
by neutrophils apart from its role in
Rap1 or integrin activation has not been
demonstrated to our knowledge.
MyD88 was important in neutrophil
recruitment and IFN-g expression, but
neither TLR2 nor TLR4 was required.
These results suggest that redundant
pathways for recognizing S. pneumoniae
exist and that other TLRs and/or pattern
recognition receptors upstream of MyD88
are sufficient to drive IFN-g production.
The defect in IFN-g production in MyD88-
deficient mice is not as large as that
observed in Nox2-deficient mice,
suggesting that other pattern recognition
receptors that do not signal through
MyD88 may be important in the
recognition of and response to S.
pneumoniae. Other pattern recognition
receptors have been shown to play
important roles in host defense against this
organism, including TLR9 (71, 72), NLRP3
(73, 74), NOD2 (75), and DAI (76). Pore
formation by pneumolysin may enable
bacterial components to enter host cells,
thereby facilitating recognition of bacterial
components by intracellular pathogen
recognition receptors. These studies do not
address whether MyD88 in neutrophils or
in other cell types, such as alveolar and
bronchial epithelial cells and alveolar
macrophages, is controlling IFN-g
production by neutrophils.
NADPH oxidase is required for IFN-g
production by neutrophils but not Nrf2,
a transcription factor that is activated by
oxidative stress. These results suggest that
NADPH oxidase may regulate IFN-g
production by modulating activation of
other oxidant-sensitive transcription
factors, such as AP-1 and NF-kB, and/or by
regulating phosphatase activity. In other
cell types, oxidants have been shown to
Table 9. Gene Set Enrichment Analysis–Identified Gene Ontology Biological Pathways
Showing Highly Significant Enrichment in Wild-Type Bone Marrow–Reconstituted
Mice with Streptococcus pneumoniae Compared with Ifng2/2 Bone
Marrow–Reconstituted Mice with S. pneumoniae (FDR < 0.0001)*
Gene Ontology Set ID Functional Term
GO:0001562 Response to protozoan
GO:0001819 Positive regulation of cytokine production
GO:0042832 Defense response to protozoan
GO:0035456 Response to IFN-b
GO:0034341 Response to IFN-g
GO:0045087 Innate immune response
GO:0031341 Regulation of cell killing
GO:0071346 Cellular response to IFN-g
GO:0045428 Regulation of nitric oxide biosynthetic process
GO:0001906 Cell killing
GO:0031343 Positive regulation of cell killing
GO:0046209 Nitric oxide metabolic process
GO:0001909 Leukocyte-mediated cytotoxicity
GO:0045429 Positive regulation of nitric oxide biosynthetic process
GO:0045088 Regulation of innate immune response
GO:0006809 Nitric oxide biosynthetic process
GO:0035458 Cellular response to IFN-b
GO:0002697 Regulation of immune effector process
GO:0032732 Positive regulation of interleukin-1 production
GO:0006955 Immune response
*These pathways were also significantly enriched in mice with high-dose S. pneumoniae compared
with PBS regardless of the donor bone marrow genotype.
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inhibit phosphatases, but our data show
that JNK phosphorylation is greater in
Nox2-deficient neutrophils. In contrast,
phosphorylation of p38 MAPK and ERK
is similar in WT and Nox2-deficient
neutrophils. Whether the observed increase
in JNK phosphorylation is the mechanism
through which IFN-g production is
inhibited in Nox2-deficient mice remains
to be determined. Neutrophils may have
evolved complex mechanisms to regulate
oxidant-responsive pathways as befits
a cell that can generate large amounts
of oxidants rapidly.
IFN-g is important for host defense
through its ability to activate neutrophils
and other innate immune cells. For
example, IFN-g was required for timely
clearance of S. pneumoniae and for the
formation of neutrophil extracellular
traps (3). Mice deficient in IFN-g have
decrements in the production of iNOS,
also important for bactericidal activity.
Moreover, this IFN-g may shape the
subsequent response by lymphocytes that
migrate into the site of infection or injury
after neutrophils. For example, Cxcl11
expression at 24 hours of pneumonia
requires IFN-g production (unpublished
data). Cxcl11 is the ligand for Cxcr3, which
is expressed on CD41 Th1 and CD81
cytotoxic lymphocytes, and Cxcl11
regulates migration of Th1 T cells into
sites of inflammation (77).
The mechanisms through which the
IFN-g produced within 24 hours after
instillation of S. pneumoniae contributes
to host defense was evaluated by gene
profiling of lungs from Ifng2/2 mice with
either Ifng2/2 or WT BM. S. pneumoniae
induces robust gene expression in the lungs,
and a significant proportion of these
induced genes are regulated by IFN-g.
Many of the genes identified in our analysis
as IFN-g–regulated genes are known IFN-g
targets that are critical players in immune
response (including Ciita, Cxcl9, Ido1, Irf1,
and Socs1). Regulation of expression of
certain genes by IFN-g may be direct, as
in transcriptional regulation of target
genes through the IFN-g receptor and
downstream STAT1 signaling, or indirect,
for example by regulating recruitment of
certain cell types. Thus, by producing IFN-
g, neutrophils can drive many processes in
the host response to bacteria in the lungs.
In summary, these studies show that, at
24 hours after instillation of S. pneumoniae,
neutrophils, but not neutrophil-dendritic
cell hybrids, produced IFN-g. No role
for IL-12 was found for this process in
neutrophils, in striking contrast to its
critical role in IFN-g production by T
lymphocytes and NK cells (Figure 6). This
IL-12–independent IFN-g production is
nearly abolished in Nox2-deficient mice,
suggesting a role for oxidants in IFN-g
expression (3). However, Nrf2, a major
transcription factor activated by oxidative
stress, is not required for IFN-g production.
These NADPH oxidase–generated oxidants
may be acting through limiting JNK
phosphorylation. Building on our previous
work showing that Src family tyrosine
kinases, Rac2, and NADPH oxidase are
required for IFN-g production, our studies
tested the role of the CD11/CD18 adhesion
complex and CD44, which network with
these signaling molecules. The data show
that CD11/CD18 adhesion complex and
CD44 are not required. The pathogen
recognition receptors TLR2 and TLR4,
either singly or in combination, are also not
required, but the TLR adaptor molecule
MyD88 is required for full expression of
IFN-g by neutrophils. Deficiency of TRIF,
the other TLR adaptor protein, induced an
increase in neutrophils and thus an increase
in the total number of IFN-g1 neutrophils,
but TRIF is not required in IFN-g
production itself. Thus, the intracellular
signaling pathway(s) that leads to IFN-g
transcription includes MyD88, Src family
tyrosine kinases, Rac2, and NADPH
oxidase–generated ROS and is negatively
regulated by CalDAG-GEFI. Neutrophils
are the only cells in the lung making IFN-g
during 24-hour S. pneumoniae pneumonia,
and this IFN-g is critical for the expression
of many genes known to regulate
macrophage activation, immune cell
recruitment, leukocyte activation, cell
killing, and other aspects of innate and
IFN-γ
PRRs?













Figure 6. Postulated pathway regulating IFN-g production by neutrophils. Recognition of S. pneumoniae
or its components by pattern recognition receptors (PRRs) results in activation of the adaptor molecule
MyD88, which we postulate leads to activation of Src family kinases (SFK) Lyn/Fgr/Hck, the small GTPase
Rac2, and NADPH oxidase. Production of oxidants by NADPH oxidase leads to production of IFN-g
through a process that does not require the oxidant-sensitive transcription factor Nrf2. IL-12 is not required
for IFN-g production by neutrophils. The adaptor molecule TRIF and the leukocyte adhesion complex
CD11/CD18 (including complement receptor 3) are also not required. The small GTPase CalDAG-GEFI
inhibits neutrophil IFN-g production. Neutrophil-derived IFN-g is critical for the expression of many genes
known to regulate macrophage activation, immune cell recruitment, leukocyte activation, cell killing, and
other aspects of innate and specific immunity. Dashed arrows indicate likely to include intervening steps.
ROS, reactive oxygen species; X, not required.
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specific immunity. These studies underline
the complexity and the importance of the
neutrophil responses in host defense in
the acute inflammatory response and in
subsequent resolution or initiation of innate
and specific immune responses. IFN-g
production by neutrophils during
pneumonia induced by S. pneumoniae
is a tightly regulated process that likely
involves interactions between multiple
signaling pathways. Understanding these
mechanisms may have important
implications for treatment of infections
and inflammatory diseases. n
Author disclosures are available with the text
of this article at www.atsjournals.org.
Acknowledgments: The authors thank
Elizabeth A. Duncan, Eric Pearlman, Casey
Weaver, Michael J. Vernon, and Wanda K.
O’Neal for their expert advice and many helpful
discussions.
References
1. Mizgerd JP. Respiratory infection and the impact of pulmonary immunity
on lung health and disease. Am J Respir Crit Care Med 2012;186:
824–829.
2. Mantovani A, Cassatella MA, Costantini C, Jaillon S. Neutrophils in the
activation and regulation of innate and adaptive immunity. Nat Rev
Immunol 2011;11:519–531.
3. Yamada M, Gomez JC, Chugh PE, Lowell CA, Dinauer MC, Dittmer DP,
Doerschuk CM. Interferon-g production by neutrophils during bacterial
pneumonia in mice. Am J Respir Crit Care Med 2011;183:1391–1401.
4. Trinchieri G. Interleukin-12 and the regulation of innate resistance and
adaptive immunity. Nat Rev Immunol 2003;3:133–146.
5. Munder M, Mallo M, Eichmann K, Modolell M. Murine macrophages
secrete interferon gamma upon combined stimulation with interleukin
(IL)-12 and IL-18: a novel pathway of autocrine macrophage
activation. J Exp Med 1998;187:2103–2108.
6. Fukao T, Matsuda S, Koyasu S. Synergistic effects of IL-4 and IL-18 on
IL-12-dependent IFN-gamma production by dendritic cells. J Immunol
2000;164:64–71.
7. Ohteki T, Fukao T, Suzue K, Maki C, Ito M, Nakamura M, Koyasu S.
Interleukin 12-dependent interferon gamma production by CD8alpha1
lymphoid dendritic cells. J Exp Med 1999;189:1981–1986.
8. Bacon CM, Petricoin EF III, Ortaldo JR, Rees RC, Larner AC, Johnston
JA, O’Shea JJ. Interleukin 12 induces tyrosine phosphorylation and
activation of STAT4 in human lymphocytes. Proc Natl Acad Sci USA
1995;92:7307–7311.
9. Thierfelder WE, van Deursen JM, Yamamoto K, Tripp RA, Sarawar SR,
Carson RT, Sangster MY, Vignali DA, Doherty PC, Grosveld GC, et al.
Requirement for Stat4 in interleukin-12-mediated responses of natural
killer and T cells. Nature 1996;382:171–174.
10. Li S, Yamauchi A, Marchal CC, Molitoris JK, Quilliam LA, Dinauer MC.
Chemoattractant-stimulated Rac activation in wild-type and Rac2-
deficient murine neutrophils: preferential activation of Rac2 and Rac2 gene
dosage effect on neutrophil functions. J Immunol 2002;169:5043–5051.
11. Bedard K, Krause KH. The NOX family of ROS-generating NADPH oxidases:
physiology and pathophysiology. Physiol Rev 2007;87:245–313.
12. Cho HY, Reddy SP, Kleeberger SR. Nrf2 defends the lung from
oxidative stress. Antioxid Redox Signal 2006;8:76–87.
13. Kobayashi M, Yamamoto M. Nrf2-Keap1 regulation of cellular defense
mechanisms against electrophiles and reactive oxygen species.
Adv Enzyme Regul 2006;46:113–140.
14. Thimmulappa RK, Lee H, Rangasamy T, Reddy SP, Yamamoto M, Kensler
TW, Biswal S. Nrf2 is a critical regulator of the innate immune response
and survival during experimental sepsis. J Clin Invest 2006;116:984–995.
15. Reddy NM, Suryanarayana V, Kalvakolanu DV, Yamamoto M, Kensler
TW, Hassoun PM, Kleeberger SR, Reddy SP. Innate immunity
against bacterial infection following hyperoxia exposure is impaired
in NRF2-deficient mice. J Immunol 2009;183:4601–4608.
16. Cho HY, Imani F, Miller-DeGraff L, Walters D, Melendi GA, Yamamoto
M, Polack FP, Kleeberger SR. Antiviral activity of Nrf2 in a murine
model of respiratory syncytial virus disease. Am J Respir Crit Care
Med 2009;179:138–150.
17. Kong X, Thimmulappa R, Craciun F, Harvey C, Singh A, Kombairaju P,
Reddy SP, Remick D, Biswal S. Enhancing Nrf2 pathway by
disruption of Keap1 in myeloid leukocytes protects against sepsis.
Am J Respir Crit Care Med 2011;184:928–938.
18. Harvey CJ, Thimmulappa RK, Sethi S, Kong X, Yarmus L, Brown RH,
Feller-Kopman D, Wise R, Biswal S. Targeting Nrf2 signaling
improves bacterial clearance by alveolar macrophages in patients
with COPD and in a mouse model. Sci Transl Med 2011;3:78ra32.
19. MacGarvey NC, Suliman HB, Bartz RR, Fu P, Withers CM, Welty-Wolf
KE, Piantadosi CA. Activation of mitochondrial biogenesis by heme
oxygenase-1-mediated NF-E2-related factor-2 induction rescues
mice from lethal Staphylococcus aureus sepsis. Am J Respir Crit
Care Med 2012;185:851–861.
20. Piantadosi CA, Withers CM, Bartz RR, MacGarvey NC, Fu P, Sweeney
TE, Welty-Wolf KE, Suliman HB. Heme oxygenase-1 couples
activation of mitochondrial biogenesis to anti-inflammatory cytokine
expression. J Biol Chem 2011;286:16374–16385.
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61. Müller U, Köhler G, Mossmann H, Schaub GA, Alber G, Di Santo JP,
Brombacher F, Hölscher C. IL-12-independent IFN-gamma
production by T cells in experimental Chagas’ disease is mediated
by IL-18. J Immunol 2001;167:3346–3353.
62. Abdelsamed HA, Desai M, Nance SC, Fitzpatrick EA. T-bet controls
severity of hypersensitivity pneumonitis. J Inflamm (Lond) 2011;8:15.
63. Yeaman GR, Collins JE, Currie JK, Guyre PM, Wira CR, Fanger MW.
IFN-gamma is produced by polymorphonuclear neutrophils in
human uterine endometrium and by cultured peripheral blood
polymorphonuclear neutrophils. J Immunol 1998;160:5145–5153.
64. Balasubramani A, Mukasa R, Hatton RD, Weaver CT. Regulation of the
Ifng locus in the context of T-lineage specification and plasticity.
Immunol Rev 2010;238:216–232.
65. Gill S, Vasey AE, De Souza A, Baker J, Smith AT, Kohrt HE, Florek M,
Gibbs KD Jr, Tate K, Ritchie DS, et al. Rapid development of
exhaustion and down-regulation of eomesodermin limit the
antitumor activity of adoptively transferred murine natural killer cells.
Blood 2012;119:5758–5768.
66. Mullen AC, High FA, Hutchins AS, Lee HW, Villarino AV, Livingston DM,
Kung AL, Cereb N, Yao TP, Yang SY, et al. Role of T-bet in
commitment of TH1 cells before IL-12-dependent selection. Science
2001;292:1907–1910.
67. Bergmeier W, Goerge T, Wang HW, Crittenden JR, Baldwin AC, Cifuni
SM, Housman DE, Graybiel AM, Wagner DD. Mice lacking the
signaling molecule CalDAG-GEFI represent a model for leukocyte
adhesion deficiency type III. J Clin Invest 2007;117:1699–1707.
68. Stadtmann A, Brinkhaus L, Mueller H, Rossaint J, Bolomini-Vittori M,
Bergmeier W, Van Aken H, Wagner DD, Laudanna C, Ley K, et al.
Rap1a activation by CalDAG-GEFI and p38 MAPK is involved in
E-selectin-dependent slow leukocyte rolling. Eur J Immunol 2011;41:
2074–2085.
69. Carbo C, Duerschmied D, Goerge T, Hattori H, Sakai J, Cifuni SM,
White GC II, Chrzanowska-Wodnicka M, Luo HR, Wagner DD.
Integrin-independent role of CalDAG-GEFI in neutrophil chemotaxis.
J Leukoc Biol 2010;88:313–319.
70. Frische EW, Zwartkruis FJ. Rap1, a mercenary among the Ras-like
GTPases. Dev Biol 2010;340:1–9.
71. Lee KS, Scanga CA, Bachelder EM, Chen Q, Snapper CM. TLR2
synergizes with both TLR4 and TLR9 for induction of the MyD88-
dependent splenic cytokine and chemokine response to
Streptococcus pneumoniae. Cell Immunol 2007;245:103–110.
72. Albiger B, Dahlberg S, Sandgren A, Wartha F, Beiter K, Katsuragi H,
Akira S, Normark S, Henriques-Normark B. Toll-like receptor 9 acts
at an early stage in host defence against pneumococcal infection.
Cell Microbiol 2007;9:633–644.
73. Witzenrath M, Pache F, Lorenz D, Koppe U, Gutbier B, Tabeling C,
Reppe K, Meixenberger K, Dorhoi A, Ma J, et al. The NLRP3
inflammasome is differentially activated by pneumolysin variants and
ORIGINAL RESEARCH
Gomez, Yamada, Martin, et al.: Neutrophil IFN-g Production 363
contributes to host defense in pneumococcal pneumonia. J Immunol
2011;187:434–440.
74. McNeela EA, Burke A, Neill DR, Baxter C, Fernandes VE, Ferreira D,
Smeaton S, El-Rachkidy R, McLoughlin RM, Mori A, et al. Pneumolysin
activates the NLRP3 inflammasome and promotes proinflammatory
cytokines independently of TLR4. PLoS Pathog 2010;6:e1001191.
75. Davis KM, Nakamura S, Weiser JN. Nod2 sensing of lysozyme-
digested peptidoglycan promotes macrophage recruitment and
clearance of S. pneumoniae colonization in mice. J Clin Invest 2011;
121:3666–3676.
76. Parker D, Martin FJ, Soong G, Harfenist BS, Aguilar JL, Ratner AJ,
Fitzgerald KA, Schindler C, Prince A. Streptococcus pneumoniae
DNA initiates type I interferon signaling in the respiratory tract. MBio
2011;2:e00016–e11.
77. Groom JR, Luster AD. CXCR3 ligands: redundant, collaborative and
antagonistic functions. Immunol Cell Biol 2011;89:207–215.
ORIGINAL RESEARCH
364 American Journal of Respiratory Cell and Molecular Biology Volume 52 Number 3 | March 2015
